In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Foghorn Therapeutics Inc (NASDAQ: FHTX) closed at $4.81 in the last session, up 1.91% from day before closing price of $4.72. In other words, the price has increased by $1.91 from its previous closing price. On the day, 0.11 million shares were traded. FHTX stock price reached its highest trading level at $4.86 during the session, while it also had its lowest trading level at $4.65.
Ratios:
We take a closer look at FHTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.16 and its Current Ratio is at 2.16.
Upgrades & Downgrades
In the most recent recommendation for this company, Guggenheim on November 07, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
On April 23, 2025, Citizens JMP started tracking the stock assigning a Mkt Outperform rating and target price of $9.Citizens JMP initiated its Mkt Outperform rating on April 23, 2025, with a $9 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FHTX now has a Market Capitalization of 272011680 and an Enterprise Value of 114262704. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.09. Its current Enterprise Value per Revenue stands at 4.66 whereas that against EBITDA is -1.373.
Stock Price History:
The Beta on a monthly basis for FHTX is 3.03, which has changed by -0.40926158 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, FHTX has reached a high of $8.44, while it has fallen to a 52-week low of $2.94. The 50-Day Moving Average of the stock is 7.34%, while the 200-Day Moving Average is calculated to be 3.17%.
Shares Statistics:
According to the various share statistics, FHTX traded on average about 196.48K shares per day over the past 3-months and 252080 shares per day over the past 10 days. A total of 56.54M shares are outstanding, with a floating share count of 27.24M. Insiders hold about 51.82% of the company’s shares, while institutions hold 39.29% stake in the company. Shares short for FHTX as of 1763078400 were 863427 with a Short Ratio of 4.39, compared to 1760486400 on 838817. Therefore, it implies a Short% of Shares Outstanding of 863427 and a Short% of Float of 2.3.
Earnings Estimates
The dynamic stock of Foghorn Therapeutics Inc (FHTX) is currently being evaluated by a team of 7.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.27 and low estimates of -$0.37.
Analysts are recommending an EPS of between -$0.89 and -$1.31 for the fiscal current year, implying an average EPS of -$1.13. EPS for the following year is -$1.06, with 7.0 analysts recommending between -$0.73 and -$1.54.
Revenue Estimates
According to 7 analysts,. The current quarter’s revenue is expected to be $10.76M. It ranges from a high estimate of $25M to a low estimate of $5M. As of. The current estimate, Foghorn Therapeutics Inc’s year-ago sales were $2.86M
A total of 8 analysts have provided revenue estimates for FHTX’s current fiscal year. The highest revenue estimate was $46.66M, while the lowest revenue estimate was $26.7M, resulting in an average revenue estimate of $32.33M. In the same quarter a year ago, actual revenue was $22.6M
